On May 12, 2021 Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, reported that the Aptose management team will participate in upcoming investor conferences (Press release, Aptose Biosciences, MAY 12, 2021, View Source [SID1234579766]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2021 RBC Capital Markets Global Healthcare Virtual Conference

Date: Wednesday, May 19, 2021
Time: 11:30 AM – 11:55 AM EDT
Format: Fireside Chat moderated by Gregory J. Renza, M.D., Equity Research – Biotechnology

Conference Information: Link
Jefferies Virtual Healthcare Conference

Date: Wednesday, June 2, 2021
Time: 2:00 PM – 2:25 PM EDT
Format: Aptose Slide Presentation and Webcast

Conference Information: Link
The Aptose management team also will be hosting 1×1 meetings during the events.